ResMed
RMD · NYSE · USD · Healthcare
1What is happening
ResMed has fallen 8% since its 6-week high on 23/10/2026. How it continues – phase and signs – you see with a free account.
Free account · 3 stocks and coins a dayfrom the 6-week high-7.9%
Other view · 17 analystsHorizon: 12 months9 Buy · 10 Hold · 1 Sell2Our assessment
Dip in progress48How it continues – phase and signs – you see with a free account.
3Your next step
Marking places no order – it only helps you keep track.
More details · reasons, figures, alerts
How deep is the dip?
- from the 6-week high-7.9%
Highest daily price: $255.57 on 23/10/2026 · reference of the assessment · also the highest of the last 3 months
- from the 52-week high-15.3%
Highest price in 52 weeks: $277.67 (Yahoo)
What analysts expect
17 analysts disagree. They look about 12 months ahead – DipCatcher only 14 trading days.
- Buy
- 945 %
- Hold
- 1050 %
- Sell
- 15 %
Average price target$264.33
$210.00 to $320.00 · today $235.30
$210.00Ø $264.33$320.00
What is a price target?
The price an analyst expects in about 12 months. Estimates are often far apart and change frequently.
Third-party opinion, not an assessment by DipCatcher. Source: public analyst estimates, as of 08/11/2026. Not financial advice.
Dates
- 12NovEx-dividendBuying from this day no longer gets the next dividend. The price usually drops by about the dividend.
- 17DecDividend paymentThe dividend is paid on this day.
- 28JanQuarterly resultsResMed reports results. Prices often move more around this date.
The company in figures
- Market value
- 33.1 bn $
- All shares together at the current price.
- P/E
- 21.4
- Price divided by earnings per share, last 12 months.
- Dividend yield
- 1.12 %
- Yearly dividend relative to the price.
- 52-week range
- $180.27 – $277.67
- Lowest and highest price of the last year.
Catalysts
37 h ago- News, last 10 days
- no recent news
- Next earnings
- 28/01/2027 · in 83 days
- Last report
- 29/10/2026 +8.9% vs estimate
Key figures
- Market value
- 33.1 bn $Large cap
- P/E
- 21.4
- Dividend yield
- 1.12 %
- Volume today
- 1.3 × Øabout usual
- Beta
- 0.76swings about like the market
- 52-week range
- $180.27 – $277.67price at 56 % of the range
About ResMed
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
- Headquarters:
- San Diego, United States
- 52-week range:
- $180.27 – $277.67
- Website:
- resmed.com
Trade levels
Why the engine says so
History for this stock or coin
Watch and alert
See which stocks they are
The engine is watching these dips right now. A free account shows the names and opens 3 full analyses a day.
- 3 full analyses a dayWith entry, target, stop and the reasons behind them.
- WatchlistFollow the stocks you care about.
Free, no payment details.
Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search
Not investment advice. Investing carries risk up to total loss.